Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Shares Outstanding (Weighted Average) (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $62.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 6.33% to $62.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.1 million through Dec 2025, up 6.33% year-over-year, with the annual reading at $62.1 million for FY2025, 6.33% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $62.1 million at Pyxis Oncology, roughly flat from $61.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $62.1 million in Q4 2025, with the low at $1.6 million in Q1 2024.